Publication: 3705

Phase II Study of Enzalutamide for Patients With Androgen Receptor–Positive Salivary Gland Cancers (Alliance A091404)
      QxMD      Google Scholar   
Citation:
J Clin Oncol vol 40 (36) 4240-4249
Year:
2022
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
12
Parents:
3082  
Children:
None
Program:
OGC
Primary Committee:
Experimental
Sec. Committees:
   
Pharmas:
Astellas  
Grants:
U10CA180821, U10CA180882, U24 CA196171; UG1CA233160, UG1CA233290, UG1CA233339, P30 CA008748, R01 DE027738 01, U10CA180868 (NRG); U10CA180888 (SWOG);  
Corr. Author:
 
Authors:
                                   
Networks:
CA824, COLUMBIA, IWORC, LAPS-CO070, LAPS-CT018, LAPS-MN026, LAPS-MO011, LAPS-NY016, MI014   
Study
Alliance-A091404
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
ORIGINAL REPORTS, Head and Neck Cancer